Company | Name | Exchange | Sector | Industry | 3 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
China Financial Leasing | Hong Kong | Financial | Investment Holding Companies | 1,704.6% | HK$55.16Cr | -159x | -2.16 | HK$1.59 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Remegen | Hong Kong | Healthcare | Biotechnology & Medical Research | 175.1% | HK$3.90KCr | -16.5x | -2.49 | HK$65.40 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -43.2% Downside | Upgrade to Pro+ | |
ImmuneOnco Biopharmaceuticals | Hong Kong | Healthcare | Biotechnology & Medical Research | 139.2% | HK$472Cr | -7x | -0.74 | HK$11.42 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ascentage Pharma | Hong Kong | Healthcare | Biotechnology & Medical Research | 136.1% | HK$2.80KCr | -30.1x | -1.11 | HK$80.90 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -22.2% Downside | Upgrade to Pro+ | |
Holly Futures Co | Hong Kong | Financial | Investment Banking & Investment Services | 128.4% | HK$1.30KCr | 50.8x | 0.51 | HK$5.06 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
China Investment and Finance | Hong Kong | Financial | Investment Banking & Investment Services | 117.6% | HK$42.50Cr | -103x | -1.03 | HK$1.03 | -7.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Walnut Capital | Hong Kong | Financial | Investment Banking & Investment Services | 106.8% | HK$129Cr | 2,352.9x | 31.45 | HK$1.23 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
China Financial International Invest | Hong Kong | Financial | Investment Holding Companies | 103.7% | HK$60.34Cr | -15.6x | -0.18 | HK$0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jacobio Pharmaceuticals Group | Hong Kong | Healthcare | Biotechnology & Medical Research | 79.2% | HK$373Cr | -18.2x | -0.4 | HK$4.72 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -56.7% Downside | Upgrade to Pro+ | |
CMBC Capital | Hong Kong | Financial | Investment Banking & Investment Services | 74.7% | HK$47.88Cr | 8.8x | 0.09 | HK$0.44 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Emperor Capital | Hong Kong | Financial | Banking Services | 74.5% | HK$65.39Cr | 9.7x | 0.05 | HK$0.10 | 9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Innocare | Hong Kong | Healthcare | Biotechnology & Medical Research | 70.6% | HK$2.69KCr | -79.6x | -1.51 | HK$12.98 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -9.6% Downside | Upgrade to Pro+ | |
Abbisko Cayman | Hong Kong | Healthcare | Biotechnology & Medical Research | 56.6% | HK$623Cr | 166.6x | 1.95 | HK$9.60 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.2% Upside | Upgrade to Pro+ | |
Lepu Scientech Medical Technology | Hong Kong | Healthcare | Healthcare Equipment & Supplies | 52% | HK$890Cr | -16.7x | 0.05 | HK$21 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -75.8% Downside | Upgrade to Pro+ | |
Guolian Securities Co | Hong Kong | Financial | Investment Banking & Investment Services | 34.5% | HK$6.09KCr | 12.7x | 0.23 | HK$4.32 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.4% Upside | Upgrade to Pro+ | |
ARTA TechFin | Hong Kong | Financial | Investment Banking & Investment Services | 25% | HK$84.33Cr | -14.4x | -0.87 | HK$0.04 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
China Merchants China Direct | Hong Kong | Financial | Investment Banking & Investment Services | 24.1% | HK$235Cr | 2.5x | 0 | HK$15.44 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Horizon Robotics | Hong Kong | Consumer Cyclicals | Automobiles & Auto Parts | 24.1% | HK$8.86KCr | -28.6x | 0.38 | HK$6.50 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fengyinhe Holdings | Hong Kong | Financial | Investment Banking & Investment Services | 22.8% | HK$104Cr | 13.3x | -2.29 | HK$3.08 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BeOne Medicines HK | Hong Kong | Healthcare | Biotechnology & Medical Research | 10.3% | HK$22.41KCr | -72.8x | -1.45 | HK$147.30 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.9% Upside | Upgrade to Pro+ | |
Visen Pharmaceuticals | Hong Kong | Healthcare | Biotechnology & Medical Research | 7.4% | HK$515Cr | -22.3x | -0.96 | HK$43.45 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Alphamab | Hong Kong | Healthcare | Biotechnology & Medical Research | 4.1% | HK$605Cr | 38.4x | 0.19 | HK$6.48 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.7% Upside | Upgrade to Pro+ | |
Mabpharm | Hong Kong | Healthcare | Biotechnology & Medical Research | 1% | HK$206Cr | -13.9x | -0.38 | HK$0.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Giant Biogene Holding | Hong Kong | Consumer Non-Cyclicals | Personal & Household Products & Services | -7.2% | HK$6.19KCr | 36.4x | 0.65 | HK$58.40 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.5% Upside | Upgrade to Pro+ | |
Tong Tong AI Social | Hong Kong | Financial | Banking Services | -11.3% | HK$143Cr | 24.4x | -1.24 | HK$0.27 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |